Pillstats
Rx only · Solution · Respiratory (Inhalation)

Ipratropium Bromide

Ipratropium Bromide

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers12 labelers
Packages30
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.032$0.064$0.096$0.127Dec 2025Mar 2026Jun 2026
$0.111
Latest avg · Jun 17, 2026
+6%
Since Dec 17, 2025
12
Active US suppliers
30%
Top-2 supplier share*

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Nephron Pharmaceuticals Corporationunknown5SUPPLYING
Aurobindo Pharma Limitedunknown4SUPPLYING
Mylan Pharmaceuticals Inc.unknown4SUPPLYING
Ritedose Pharmaceuticals, LLCunknown4SUPPLYING
Rising Pharma Holdings, Inc.unknown3SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
Redpharm Drugunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.